Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Int J Cardiol. 2018 Jun 22;270:48–53. doi: 10.1016/j.ijcard.2018.06.086

Table 2. Imaging data for patients and controls.

Cardiac magnetic resonance measures for the reference controls (n=12 females) and INOCA subjects (n=22 females).

Reference
Controls
INOCA
Subjects
p value
MPRI 2.49 ± 0.41 1.78 ± 0.39 < 0.0001*
Presence of LGE 0 0 --
LV EF (%) 67.7 ± 1.7 68.2 ± 6.2 0.787
LV ED volume (ml) 127.5 ± 18.3 127.1 ± 25.4 0.964
LV ES volume (ml) 41.2 ± 6.32 41.2 ± 15.5 0.998
LV stroke volume (ml) 84.0 ± 12.4 85.9 ± 14.1 0.690
LV mass (g) 74.4 ± 17.3 85.5 ± 21.7 0.136
LV mass index (g/m2) 41.7 ± 7.0 47.1 ± 12.1 0.169
Presence of LV hypertrophy 0 1 (5 %) --
Cardiac output 5.32 ± 1.21 5.86 ± 1.58 0.332
Systolic circumferential −19.7 ± 2.24 −18.3 ± 3.33 0.235
        strain (%)
Systolic circumferential −94.1 ± 13.0 −94.8 ± 19.3 0.919
        strain rate (%/s)
Diastolic circumferential 126.0 ± 34.9 102.7 ± 29.9 0.055
        strain rate (%/s)
Global native 1003.8 ± 18.5 1040.1 ± 29.3 < 0.001*
    myocardial T1 (ms)
Septal native 1019.5 ± 20.8 1054.7 ± 30.2 0.001*
    myocardial T1 (ms)
Resting systolic BP (mmHg) 121.7 ± 14.3 128.6 ± 18.9 0.210
Resting HR (beats per minute) 60.9 ± 10.9 66.9 ± 8.3 0.286
Stress HR (beats per minute) 96.7 ± 19.1 92.6 ± 12.7 0.474
Resting rate-pressure product 7409±1493 8623±1711 0.129
Stress rate-pressure product 11425±2467 11813± 1965 0.629
*

indicates statistical significance.

Values are mean ± standard deviation or number (percentage).

INOCA = ischemia and no obstructive coronary artery disease; ED = end diastolic; ES = end systolic; EF = ejection fraction; LGE = late gadolinium enhancement; LV = left ventricular; MPRI = myocardial perfusion reserve index; BP = blood pressure; HR = heart rate.